Skip to main content
. 2019 Mar 19;11(3):278. doi: 10.3390/v11030278

Table 1.

Summary of sequencing data.

Sample Raw Reads
(Mb)
Clean Reads Clean Reads
(Mb)
Clean Bases
(Gb)
Clean Reads
Q30(%) b
Clean Reads
Ratio(%) c
Total Mapping
Ratio d
Sequencing
Depth e
S0_1 a 35.05 30,212,592 30.21 4.53 95.28 86.19 83.80% 120ⅹ
S0_2 a 33.46 29,391,054 29.39 4.41 95.27 87.84 84.39% 117ⅹ
S0_3 a 35.05 30,596,914 30.60 4.59 95.65 87.29 82.51% 121ⅹ
S1_1 a 35.05 30,378,866 30.38 4.56 95.57 86.66 84.01% 121ⅹ
S1_2 a 35.05 30,624,970 30.62 4.59 95.94 87.37 85.72% 121ⅹ
S1_3 a 33.46 29,485,096 29.49 4.42 95.78 88.12 86.05% 117ⅹ

a S0_1, S0_2, S0_3: Three biological replicates of SsHADV-1 free sample. S1_1, S1_2, S1_3: three biological replicates of SsHADV-1 infection sample; b Clean Reads Q30(%): Percentages of clean bases whose correct base recognition rates are greater than 99.9% in total bases; c Clean Reads Ratio: Clean reads/raw reads; d Total Mapping Ratio: Genome mapping reads/raw reads; e Sequencing depth: Clean bases/genome size.